Filing Details

Accession Number:
0001415889-23-005415
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-24 21:35:26
Reporting Period:
2023-03-22
Accepted Time:
2023-03-24 21:35:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1857843 Daniel Rabinowitz C/O Natera, Inc.
13011 Mccallen Pass Building A Suite 100
Austin TX 78753
Sec. And Chief Legal Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-03-22 2,864 $56.32 175,387 No 4 S Direct
Common Stock Acquisiton 2023-03-22 893 $0.00 176,280 No 4 M Direct
Common Stok Disposition 2023-03-23 474 $56.08 175,806 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2023-03-22 893 $0.00 893 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units ("RSUs")and in compliance with Rule 10b5-1.
  2. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  3. The RSUs vest over four years. 25% of the RSUs vested on March 22, 2020 and the remaining shares vest in 12 equal quarterly installments thereafter.